| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Imatinib Mesylate | FAERS: 10 | US FAERS | |
| 2 | Temozolomide | FAERS: 10 | US FAERS | |
| 3 | osimertinib | FAERS: 10 | US FAERS | |
| 4 | Gefitinib | FAERS: 5 | US FAERS | |
| 5 | Valacyclovir | FAERS: 5 | US FAERS | |
| 6 | Dasatinib | FAERS: 4 | US FAERS | |
| 7 | Afatinib | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Lenalidomide | FAERS: 3 | US FAERS | |
| 9 | dolutegravir | FAERS: 3 | US FAERS | |
| 10 | olaparib | FAERS: 3 | US FAERS | |
| 11 | Anastrozole | FAERS: 2 | US FAERS | |
| 12 | Emtricitabine | FAERS: 2 | US FAERS | |
| 13 | Erlotinib Hydrochloride | FAERS: 2 | US FAERS | |
| 14 | Letrozole | FAERS: 2 | US FAERS | |
| 15 | Levofloxacin | FAERS: 2 | US FAERS | |
| 16 | acalabrutinib | FAERS: 2 | US FAERS | |
| 17 | ponatinib | FAERS: 2 | US FAERS | |
| 18 | Azacitidine | FAERS: 1 | US FAERS | |
| 19 | Ciprofloxacin | FAERS: 1 | US FAERS | |
| 20 | Clopidogrel | FAERS: 1 | US FAERS | |
| 21 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 22 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 23 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 24 | NuvaRing | FAERS: 1 | US FAERS | |
| 25 | Rifampin | FAERS: 1 | US FAERS | |
| 26 | niraparib | FAERS: 1 | US FAERS | |
| 27 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.